The artificial organ market size has grown rapidly in recent years. It will grow from $25.73 billion in 2025 to $28.36 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing organ failure cases, shortage of donor organs, advancements in biomedical engineering, growth of dialysis and cardiac support therapies, expanding transplant waiting lists.
The artificial organ market size is expected to see strong growth in the next few years. It will grow to $41.12 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing investments in bioengineered organs, rising adoption of personalized implant solutions, expansion of artificial organ research funding, technological progress in regenerative medicine, growing acceptance of long-term implantable devices. Major trends in the forecast period include increasing adoption of implantable artificial organs, rising use of advanced biomaterials, growing integration of smart and sensor-enabled organs, expansion of minimally invasive implantation techniques, enhanced focus on long-term biocompatibility.
The growing need for organ transplants is anticipated to support the expansion of the artificial organ market in the coming years. Organ transplantation refers to a medical procedure in which an organ or tissue is taken from a donor and surgically implanted into a recipient to replace a damaged or failing organ. Artificial organ technologies support transplantation by offering temporary or permanent organ substitutes, reducing reliance on donor availability and enhancing patient survival outcomes. For example, in July 2025, according to a report released by NHS Blood and Transplant, a United Kingdom-based government organization, as of March 2025, 8,096 patients, including 276 children, were registered on the active transplant waiting list, representing the highest level ever recorded. In addition, nearly 3,883 individuals were temporarily suspended, resulting in almost 12,000 people facing ongoing uncertainty regarding access to life-saving transplants. Consequently, the rising demand for organ transplants is contributing to the growth of the artificial organ market.
Leading companies operating in the artificial organ market are increasingly prioritizing innovative offerings, such as artificial intelligence-enabled pathology solutions, to strengthen revenue generation. AI-powered pathology solutions are reshaping the pathology landscape by equipping pathologists with advanced tools that enhance diagnostic precision, operational efficiency, and patient outcomes. For instance, in September 2023, Aiosyn, a Netherlands-based medical software company specializing in AI-driven pathology solutions, introduced an AI kidney suite. This solution is designed to objectively quantify kidney lesion scores, improve result consistency, and accelerate drug discovery through AI-enabled computational pathology methods. The platform enables research institutions and biopharmaceutical companies to examine kidney structures and measure lesions affecting renal health by leveraging advanced deep-learning technology.
In March 2024, Nippon Express Holdings, Inc., a Japan-based logistics services provider, acquired a stake in Instalimb, Inc. for an undisclosed amount. This acquisition is intended to enhance Nippon's corporate value while tackling social issues. The investment will support Instalimb's logistics and business growth in Asian markets and potentially in emerging regions of Africa in the future. Instalimb, Inc. is a Japan-based start-up that specializes in 3D-printed prosthetics.
Major companies operating in the artificial organ market are Medtronic plc, Abbott Laboratories Inc., SynCardia Systems LLC, Berlin Heart GmbH, ABIOMED Inc., Carmat SA, Jarvik Heart Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Organovo Holdings Inc., Satellite Bio, HeartWare plc, Boston Scientific Services Private Limited, Edwards Lifesciences India Pvt. Ltd., LIVANOVA plc, NeuroPace Inc., Cochlear Limited, Cyberonics Inc., Demant A/S, LifeNet Health Inc., Vivani Medical Inc., Tissium SAS.
North America was the largest region in the artificial organ market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organ market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial organ market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial organ market by increasing costs of imported biomaterials, precision manufacturing equipment, electronic control systems, and implantable components. Hospitals and research institutions in North America and Europe are most affected due to reliance on imported high-grade materials, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing device prices and slowing adoption rates. However, they are also driving domestic production, localized biomaterial sourcing, and regional innovation in artificial organ development.
The artificial organ market research report is one of a series of new reports that provides artificial organ market statistics, including artificial organ industry global market size, regional shares, competitors with a artificial organ market share, detailed artificial organ market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ industry. This artificial organ market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial organs are devices designed to be implanted or integrated into the human body, serving the purpose of replacing, duplicating, or augmenting specific functions to enable patients to return to normal life.
The primary types of artificial organs encompass artificial hearts, artificial kidneys, artificial livers, artificial pancreas, and others. For instance, an artificial heart is an implanted pump that takes over the function of damaged heart ventricles and valves. It is operated by an external mechanism called a driver. These devices are made from materials such as silicone, plastic, steel, and biomaterials, and can be fixed through implantable or external means. Various end-users benefit from artificial organs, including hospitals, ambulatory surgical centers, laboratories, diagnostic centers, research institutions, and academic institutes.
The artificial organ market consists of sales of orthopedic devices, neuroprostheses and neurological support, urological support, visual support systems, blood cell and tissue replacement systems, mechanical organs made of inanimate polymers, and biomechanical organs made of partially living cells and inanimate polymers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The artificial organ market size is expected to see strong growth in the next few years. It will grow to $41.12 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing investments in bioengineered organs, rising adoption of personalized implant solutions, expansion of artificial organ research funding, technological progress in regenerative medicine, growing acceptance of long-term implantable devices. Major trends in the forecast period include increasing adoption of implantable artificial organs, rising use of advanced biomaterials, growing integration of smart and sensor-enabled organs, expansion of minimally invasive implantation techniques, enhanced focus on long-term biocompatibility.
The growing need for organ transplants is anticipated to support the expansion of the artificial organ market in the coming years. Organ transplantation refers to a medical procedure in which an organ or tissue is taken from a donor and surgically implanted into a recipient to replace a damaged or failing organ. Artificial organ technologies support transplantation by offering temporary or permanent organ substitutes, reducing reliance on donor availability and enhancing patient survival outcomes. For example, in July 2025, according to a report released by NHS Blood and Transplant, a United Kingdom-based government organization, as of March 2025, 8,096 patients, including 276 children, were registered on the active transplant waiting list, representing the highest level ever recorded. In addition, nearly 3,883 individuals were temporarily suspended, resulting in almost 12,000 people facing ongoing uncertainty regarding access to life-saving transplants. Consequently, the rising demand for organ transplants is contributing to the growth of the artificial organ market.
Leading companies operating in the artificial organ market are increasingly prioritizing innovative offerings, such as artificial intelligence-enabled pathology solutions, to strengthen revenue generation. AI-powered pathology solutions are reshaping the pathology landscape by equipping pathologists with advanced tools that enhance diagnostic precision, operational efficiency, and patient outcomes. For instance, in September 2023, Aiosyn, a Netherlands-based medical software company specializing in AI-driven pathology solutions, introduced an AI kidney suite. This solution is designed to objectively quantify kidney lesion scores, improve result consistency, and accelerate drug discovery through AI-enabled computational pathology methods. The platform enables research institutions and biopharmaceutical companies to examine kidney structures and measure lesions affecting renal health by leveraging advanced deep-learning technology.
In March 2024, Nippon Express Holdings, Inc., a Japan-based logistics services provider, acquired a stake in Instalimb, Inc. for an undisclosed amount. This acquisition is intended to enhance Nippon's corporate value while tackling social issues. The investment will support Instalimb's logistics and business growth in Asian markets and potentially in emerging regions of Africa in the future. Instalimb, Inc. is a Japan-based start-up that specializes in 3D-printed prosthetics.
Major companies operating in the artificial organ market are Medtronic plc, Abbott Laboratories Inc., SynCardia Systems LLC, Berlin Heart GmbH, ABIOMED Inc., Carmat SA, Jarvik Heart Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Organovo Holdings Inc., Satellite Bio, HeartWare plc, Boston Scientific Services Private Limited, Edwards Lifesciences India Pvt. Ltd., LIVANOVA plc, NeuroPace Inc., Cochlear Limited, Cyberonics Inc., Demant A/S, LifeNet Health Inc., Vivani Medical Inc., Tissium SAS.
North America was the largest region in the artificial organ market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organ market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the artificial organ market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the artificial organ market by increasing costs of imported biomaterials, precision manufacturing equipment, electronic control systems, and implantable components. Hospitals and research institutions in North America and Europe are most affected due to reliance on imported high-grade materials, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing device prices and slowing adoption rates. However, they are also driving domestic production, localized biomaterial sourcing, and regional innovation in artificial organ development.
The artificial organ market research report is one of a series of new reports that provides artificial organ market statistics, including artificial organ industry global market size, regional shares, competitors with a artificial organ market share, detailed artificial organ market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ industry. This artificial organ market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Artificial organs are devices designed to be implanted or integrated into the human body, serving the purpose of replacing, duplicating, or augmenting specific functions to enable patients to return to normal life.
The primary types of artificial organs encompass artificial hearts, artificial kidneys, artificial livers, artificial pancreas, and others. For instance, an artificial heart is an implanted pump that takes over the function of damaged heart ventricles and valves. It is operated by an external mechanism called a driver. These devices are made from materials such as silicone, plastic, steel, and biomaterials, and can be fixed through implantable or external means. Various end-users benefit from artificial organs, including hospitals, ambulatory surgical centers, laboratories, diagnostic centers, research institutions, and academic institutes.
The artificial organ market consists of sales of orthopedic devices, neuroprostheses and neurological support, urological support, visual support systems, blood cell and tissue replacement systems, mechanical organs made of inanimate polymers, and biomechanical organs made of partially living cells and inanimate polymers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Artificial Organ Market Characteristics
3. Artificial Organ Market Supply Chain Analysis
4. Global Artificial Organ Market Trends and Strategies
5. Artificial Organ Market Analysis of End Use Industries
7. Global Artificial Organ Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Artificial Organ Total Addressable Market (TAM) Analysis for the Market
9. Artificial Organ Market Segmentation
10. Artificial Organ Market Regional and Country Analysis
11. Asia-Pacific Artificial Organ Market
12. China Artificial Organ Market
13. India Artificial Organ Market
14. Japan Artificial Organ Market
15. Australia Artificial Organ Market
16. Indonesia Artificial Organ Market
17. South Korea Artificial Organ Market
18. Taiwan Artificial Organ Market
19. South East Asia Artificial Organ Market
20. Western Europe Artificial Organ Market
21. UK Artificial Organ Market
22. Germany Artificial Organ Market
23. France Artificial Organ Market
24. Italy Artificial Organ Market
25. Spain Artificial Organ Market
26. Eastern Europe Artificial Organ Market
27. Russia Artificial Organ Market
28. North America Artificial Organ Market
29. USA Artificial Organ Market
30. Canada Artificial Organ Market
31. South America Artificial Organ Market
32. Brazil Artificial Organ Market
33. Middle East Artificial Organ Market
34. Africa Artificial Organ Market
36. Artificial Organ Market Competitive Landscape and Company Profiles
37. Artificial Organ Market Other Major and Innovative Companies
40. Artificial Organ Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Artificial Organ Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses artificial organ market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for artificial organ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial organ market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Organ Type: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Pancreas2) By Material: Silicone; Plastic; Steel; Biomaterials
3) By Fixation: Implantable; External
4) By End Users: Hospitals; Ambulatory Surgical Centers; Other End Users
Subsegments:
1) By Artificial Heart: Total Artificial Heart; Ventricular Assist Devices (VADs)2) By Artificial Kidney: Hemodialysis Systems; Peritoneal Dialysis Devices
3) By Artificial Liver: Bioartificial Liver Devices; Liver Support Systems
4) By Artificial Pancreas: Closed-Loop Insulin Delivery Systems; Bionic Pancreas Systems
Companies Mentioned: Medtronic plc; Abbott Laboratories Inc.; SynCardia Systems LLC; Berlin Heart GmbH; ABIOMED Inc.; Carmat SA; Jarvik Heart Inc.; Baxter International Inc.; B. Braun Melsungen AG; Terumo Corporation; Organovo Holdings Inc.; Satellite Bio; HeartWare plc; Boston Scientific Services Private Limited; Edwards Lifesciences India Pvt. Ltd.; LIVANOVA plc; NeuroPace Inc.; Cochlear Limited; Cyberonics Inc.; Demant A/S; LifeNet Health Inc.; Vivani Medical Inc.; Tissium SAS
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Artificial Organ market report include:- Medtronic plc
- Abbott Laboratories Inc.
- SynCardia Systems LLC
- Berlin Heart GmbH
- ABIOMED Inc.
- Carmat SA
- Jarvik Heart Inc.
- Baxter International Inc.
- B. Braun Melsungen AG
- Terumo Corporation
- Organovo Holdings Inc.
- Satellite Bio
- HeartWare plc
- Boston Scientific Services Private Limited
- Edwards Lifesciences India Pvt. Ltd.
- LIVANOVA plc
- NeuroPace Inc.
- Cochlear Limited
- Cyberonics Inc.
- Demant A/S
- LifeNet Health Inc.
- Vivani Medical Inc.
- Tissium SAS
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 28.36 Billion |
| Forecasted Market Value ( USD | $ 41.12 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
